STOCK TITAN

Vanguard realignment: Progyny (PGNY) Schedule 13G/A shows 0 shares

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Progyny Inc disclosure: The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of Progyny's common stock. The filing explains an internal realignment effective January 12, 2026, causing certain Vanguard subsidiaries to report holdings separately.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did The Vanguard Group report for PGNY in Amendment No. 5?

Answer: The Vanguard Group reported 0 shares beneficially owned, equal to 0% of common stock. The filing states Vanguard underwent an internal realignment on January 12, 2026, leading subsidiaries to report separately.

Does Vanguard still have voting or dispositive power over PGNY shares?

Answer: The filing states Vanguard has 0 sole and 0 shared voting powers and 0 sole and 0 shared dispositive powers for PGNY common stock as reported in the amendment.

Why does the Schedule 13G/A show zero ownership for Vanguard?

Answer: The amendment explains an internal realignment where certain Vanguard subsidiaries now report beneficial ownership separately in reliance on SEC Release No. 34-39538, and Vanguard no longer is deemed to beneficially own those subsidiary-held securities.

Who signed the filing on behalf of The Vanguard Group for PGNY?

Answer: The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/27/2026, attesting to the Schedule 13G/A amendment details.

Does the amendment identify any other persons holding more than 5% of PGNY?

Answer: The filing states that no other person's interest in the securities reported is more than 5%. It lists Vanguard-managed accounts but confirms no single outside person exceeds the 5% threshold.





74340E103

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026